ZA99981B - Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors. - Google Patents

Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.

Info

Publication number
ZA99981B
ZA99981B ZA9900981A ZA99981A ZA99981B ZA 99981 B ZA99981 B ZA 99981B ZA 9900981 A ZA9900981 A ZA 9900981A ZA 99981 A ZA99981 A ZA 99981A ZA 99981 B ZA99981 B ZA 99981B
Authority
ZA
South Africa
Prior art keywords
benzoxazinones
reverse transcriptase
oral liquid
liquid formulations
transcriptase inhibitors
Prior art date
Application number
ZA9900981A
Other languages
English (en)
Inventor
Surendra M Bahal
Michael B Maurin
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of ZA99981B publication Critical patent/ZA99981B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9900981A 1998-02-17 1999-02-08 Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors. ZA99981B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7488198P 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
ZA99981B true ZA99981B (en) 2000-08-08

Family

ID=22122226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900981A ZA99981B (en) 1998-02-17 1999-02-08 Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.

Country Status (19)

Country Link
US (1) US6235733B1 (xx)
EP (1) EP1054674B1 (xx)
JP (1) JP2002502878A (xx)
CN (1) CN1170541C (xx)
AR (1) AR018092A1 (xx)
AT (1) ATE345802T1 (xx)
AU (1) AU745008C (xx)
BR (2) BRPI9908132C1 (xx)
CA (1) CA2319609C (xx)
DE (1) DE69934097T2 (xx)
ES (1) ES2277429T3 (xx)
HK (1) HK1030749A1 (xx)
HR (1) HRP990049A2 (xx)
IL (1) IL137763A0 (xx)
MY (1) MY139034A (xx)
NZ (1) NZ506579A (xx)
TW (1) TW528596B (xx)
WO (1) WO1999040921A2 (xx)
ZA (1) ZA99981B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019530727A (ja) * 2016-10-11 2019-10-24 オクタ ファーマシューティカルズ ラモトリギンを含む経口懸濁液用の粉末

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0484281T4 (da) * 1990-11-02 2001-02-05 Novartis Ag Cyclosporiner
US5494936A (en) * 1992-04-27 1996-02-27 Vyrex Corporation Delivery formulation for probucol
US5519021A (en) 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
WO1995020389A1 (en) 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
JP2000509392A (ja) 1996-05-02 2000-07-25 メルク エンド カンパニー インコーポレーテッド Aidsの治療に有効なhivプロテアーゼ阻害剤
EP0929533B1 (en) * 1996-10-02 2003-09-03 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
BRPI9908132B8 (pt) 2016-11-16
EP1054674A2 (en) 2000-11-29
DE69934097D1 (de) 2007-01-04
ATE345802T1 (de) 2006-12-15
CA2319609A1 (en) 1999-08-19
ES2277429T3 (es) 2007-07-01
JP2002502878A (ja) 2002-01-29
BRPI9908132B1 (pt) 2015-07-14
CN1291098A (zh) 2001-04-11
AR018092A1 (es) 2001-10-31
WO1999040921A3 (en) 1999-11-04
BRPI9908132C1 (pt) 2021-05-25
AU745008B2 (en) 2002-03-07
MY139034A (en) 2009-08-28
CN1170541C (zh) 2004-10-13
NZ506579A (en) 2002-11-26
EP1054674B1 (en) 2006-11-22
US6235733B1 (en) 2001-05-22
TW528596B (en) 2003-04-21
DE69934097T2 (de) 2007-06-28
AU745008C (en) 2003-03-27
HRP990049A2 (en) 1999-12-31
AU2682799A (en) 1999-08-30
WO1999040921A2 (en) 1999-08-19
CA2319609C (en) 2007-09-18
IL137763A0 (en) 2001-10-31
BR9908132A (pt) 2000-12-05
HK1030749A1 (en) 2001-05-18

Similar Documents

Publication Publication Date Title
SG80631A1 (en) Inhibitors of hiv reverse transcriptase
AU1694295A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
IL132188A0 (en) 4,4- Disubstituted-3,4-dihydro-2 (H)-quinazolineones useful as hiv reverse transcriptase inhibitors
AU3461299A (en) Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
AU6840501A (en) Structures and compositions increasing the stability of peroxide actives
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
IL156354A0 (en) Pyridoindole derivatives and pharmaceutical compositions containing the same
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
BR9901959B1 (pt) absorvente higiÊnico.
HUP0202593A3 (en) Benzophenones as inhibitors of reverse transcriptase
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
ATE231393T1 (de) Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend
MXPA01011293A (es) Composiciones anticonceptivas que contienen derivados de quinazolinona y benzoxazina.
IL149219A0 (en) Tricyclic compounds useful as hiv reverse transcriptase inhibitors
WO2001041737A3 (en) Solid oral dosage form
MA26491A1 (fr) Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .
HK1038884A1 (en) Medicinal compositions.
HUP0105003A2 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
IL152094A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
MXPA03000694A (es) Nuevo uso de los inhibidores de lipasa.
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
FR2776660B1 (fr) Diazepino-indoles de phosphodiesterases iv
ZA99978B (en) Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.
ZA99981B (en) Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.